Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of CYP2D6*10 on H1-antihistamine-induced hypersomnia.
Saruwatari J, Matsunaga M, Ikeda K, Nakao M, Oniki K, Seo T, Mihara S, Marubayashi T, Kamataki T, Nakagawa K. Saruwatari J, et al. Eur J Clin Pharmacol. 2006 Dec;62(12):995-1001. doi: 10.1007/s00228-006-0210-3. Epub 2006 Nov 7. Eur J Clin Pharmacol. 2006. PMID: 17089107
The combination of mitochondrial low enzyme-activity aldehyde dehydrogenase 2 allele and superoxide dismutase 2 genotypes increases the risk of hypertension in relation to alcohol consumption.
Nakagawa T, Kajiwara A, Saruwatari J, Hamamoto A, Kaku W, Oniki K, Mihara S, Ogata Y, Nakagawa K. Nakagawa T, et al. Among authors: saruwatari j. Pharmacogenet Genomics. 2013 Jan;23(1):34-7. doi: 10.1097/FPC.0b013e32835b1707. Pharmacogenet Genomics. 2013. PMID: 23111423
Clinical features associated with a rapid decline in renal function among Japanese patients with type 2 diabetes mellitus: microscopic hematuria coexisting with diabetic retinopathy.
Sakata M, Oniki K, Kita A, Kajiwara A, Uchiyashiki Y, Saruwatari J, Yoshida A, Jinnouchi H, Nakagawa K. Sakata M, et al. Among authors: saruwatari j. Diabetes Res Clin Pract. 2013 May;100(2):e39-41. doi: 10.1016/j.diabres.2013.01.031. Epub 2013 Feb 19. Diabetes Res Clin Pract. 2013. PMID: 23433540
Risk factors for adverse symptoms during dipeptidyl peptidase-IV inhibitor therapy: a questionnaire-based study carried out by the Japan Pharmaceutical Association Drug Event Monitoring project in Kumamoto Prefecture.
Kajiwara A, Saruwatari J, Sakata M, Morita K, Kita A, Oniki K, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Nakagawa K. Kajiwara A, et al. Among authors: saruwatari j. Drug Saf. 2013 Oct;36(10):981-7. doi: 10.1007/s40264-013-0077-z. Drug Saf. 2013. PMID: 23743694
Sex differences in the effect of cytochrome P450 2C19 polymorphisms on the risk of diabetic retinopathy: a retrospective longitudinal study in Japanese patients with type 2 diabetes.
Kajiwara A, Saruwatari J, Kita A, Kamihashi R, Miyagawa H, Sakata M, Noai M, Oniki K, Yoshida A, Jinnouchi H, Nakagawa K. Kajiwara A, et al. Among authors: saruwatari j. Pharmacogenet Genomics. 2013 Dec;23(12):717-20. doi: 10.1097/FPC.0000000000000009. Pharmacogenet Genomics. 2013. PMID: 24113215
112 results